Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's ...

Abbott expended its manufacturing capacity with the launch of a new facility in Kilkenny, Ireland, to produce sensors for ...

The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim from Dexcom ...

Diabetes patients in the US will have greater flexibility in managing insulin delivery after Insulet announced its Omnipod pump is now compatible with Abbott’s FreeStyle Libre 2 Plus continuous ...

Abbott medical device leader Lisa Earnhardt says her group wants fewer suppliers — but to make them into long-term partners.

The system – which already has a breakthrough device designation from the FDA – will take the form of a small patch-like device similar to Abbott's FreeStyle Libre 3 device (pictured above ...

Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S. Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

Pharmacies have been turning patients away as deliveries of healthcare firm Abbott's Freestyle Libre Sensor are delayed by two or three weeks. Abbott has said it is working hard to fulfil all the ...

System is now compatible with Abbott’s FreeStyle Libre 2 Plus continuous glucose monitoring (CGM) sensor in the U.S. This makes Omnipod 5 the most connected tubeless AID system in the U.S. "We ...